Your browser doesn't support javascript.
loading
Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression.
Ortega, Roberto A; Wang, Cuiling; Raymond, Deborah; Bryant, Nicole; Scherzer, Clemens R; Thaler, Avner; Alcalay, Roy N; West, Andrew B; Mirelman, Anat; Kuras, Yuliya; Marder, Karen S; Giladi, Nir; Ozelius, Laurie J; Bressman, Susan B; Saunders-Pullman, Rachel.
Affiliation
  • Ortega RA; Department of Neurology, Mount Sinai Beth Israel, and Icahn School of Medicine, Mount Sinai, New York, New York.
  • Wang C; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York.
  • Raymond D; Department of Neurology, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York.
  • Bryant N; Department of Neurology, Mount Sinai Beth Israel, and Icahn School of Medicine, Mount Sinai, New York, New York.
  • Scherzer CR; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina.
  • Thaler A; Center for Advanced Parkinson Research and Precision Neurology Program, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.
  • Alcalay RN; Laboratory for Early Markers of Neurodegeneration, Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Medical Center, Sackler School of Medicine, Sagol School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • West AB; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
  • Mirelman A; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina.
  • Kuras Y; Laboratory for Early Markers of Neurodegeneration, Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Medical Center, Sackler School of Medicine, Sagol School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Marder KS; Center for Advanced Parkinson Research and Precision Neurology Program, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.
  • Giladi N; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
  • Ozelius LJ; Laboratory for Early Markers of Neurodegeneration, Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Medical Center, Sackler School of Medicine, Sagol School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Bressman SB; Department of Neurology, Massachusetts General Hospital, Boston.
  • Saunders-Pullman R; Department of Neurology, Mount Sinai Beth Israel, and Icahn School of Medicine, Mount Sinai, New York, New York.
JAMA Netw Open ; 4(4): e215845, 2021 04 01.
Article in En | MEDLINE | ID: mdl-33881531
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Cognitive Dysfunction / Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / Glucosylceramidase Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: JAMA Netw Open Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Cognitive Dysfunction / Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / Glucosylceramidase Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: JAMA Netw Open Year: 2021 Type: Article